In breast cancer, LSD1 expression increases with progression from ductal carcinomas in situ (DCIS) to invasive ductal carcinoma19 and overexpression is positively correlated with estrogen receptor negative (ER−) status20. This evidence concerns the gene KDM1A and breast cancer.